TB 500 from Kalpa Pharmaceuticals is a freeze-dried piece of a protein the body makes on its own, and the word fragment is not decoration: what sits in the vial is a shortened sequence rather than the whole thymosin beta-4 molecule, which is why the name and the chemistry do not line up perfectly.
The peptide circulates in repair discussions rather than in clinic shelves. Nothing here has an approved indication, an approved amount or a human half-life, and the schedules that are followed come from vendor material and from animal work. The page keeps to that boundary.
Product Overview
Thymosin beta-4 is a small protein involved in the movement and survival of cells, and the fragment sold as TB-500 is built around the short sequence that carries that activity. The mechanism discussed in the research is actin binding and cell migration towards damaged tissue, which is a different route from the growth-hormone family and a different one again from the local acting BPC 157 in the same catalogue.
What the peptide does not have is a human dataset. The half-life is listed as not established, and the clearest detection evidence comes from veterinary work, where a metabolite of the peptide was measured in the urine and plasma of horses. There is no equivalent human elimination figure, so a statement about how long the compound stays active would be invention rather than information.
Sporting status is the one area with no ambiguity. Class S2 names thymosin beta-4 and its derivatives, TB-500 among them, and bans them at every moment; with no approved medical use anywhere, a therapeutic-use exemption is not a realistic route.
Dosage Protocol
The amounts below are the vendor schedule that the sources record, not a clinical dose. Mixing arithmetic comes first because every draw depends on it.
| Beginner | Loading: 2.0 to 2.5 mg twice weekly for the first four weeks |
| Intermediate | Maintenance after loading: 2.0 to 2.5 mg once weekly |
| Advanced | Blocks of six to eight weeks, then a break of comparable length, by vendor direction |
| Female | No confirmed female protocol in the sources reviewed; the vendor material does not separate the sexes |
| Administration | Subcutaneous injection, systemic rather than into the injured area |
Mixing decides every draw, so start there. Draw 1 ml of water into the 5 mg vial and each millilitre holds 5 mg: the ten-unit mark on a U-100 barrel is 0.5 mg, and a 2 mg draw fills forty units. Use 2 ml instead and the strength per millilitre halves, so that same 2 mg now needs eighty units. That single choice sets the shelf life of the bottle, since one vial lasts about a week of the loading phase or two to two and a half weeks of maintenance. Add Bacteriostatic Water gently, swirl without shaking, and keep the prepared solution cold and inside the vendor window.
Suggested Protocols
The repair corner of the catalogue is small, and the arrangements below are how the peptides are discussed together rather than validated combinations.
Someone running a steroid course at the same time needs to remember that this peptide has no share in that plan: the recovery drugs for a hormonal course, Nolvaxyl 20 and Clomixyl 50, work on the axis, which TB 500 does not touch.
What to Expect
- Reports describe comfort before structure. Vendor and user accounts place the first changes in movement and discomfort within one to three weeks, which is early for a tissue process.
- The schedule assumes six to eight weeks. Short courses aimed at one event have no documented timeline attached to them.
- Nothing measurable outside a clinic. No validated marker follows the course, so improvement is judged by how the person feels and moves.
- The half-life is a blank. With no human pharmacokinetics, timing and duration rest entirely on vendor convention.
- Safety data in humans are thin. Long-term use in healthy people has never been formally studied.
- Testing is permanent. The peptide is prohibited at all times in sport, with no realistic route to an exemption.
Side Effects and Management
After the Block and Follow-Up
This peptide leaves the hormonal axis alone, so a recovery phase built on a SERM has no work to do here. The block simply ends.
If a hormonal course is running alongside, its recovery is governed by its own esters and belongs to that course, whether the base is the mix Sustaxyl 350 or an ester such as Testoxyl Enanthate 250. The peptide takes no part in that calculation.
Storage and Ordering
Store the sealed vial in the cold and the dark, and the reconstituted solution in the fridge used inside the vendor window; repeated freezing and thawing is the fastest way to waste a bottle. On delivery, read the batch code, note the expiry, and compare the label against the Kalpa Pharmaceuticals catalogue entry for this strength, since peptide vials are easier to counterfeit than tablets.
Everything ships in discreet outer packaging, and delivery choices sit on the product page beside the pack details.
